[
    {
        "example_id": 157,
        "problem": [
            "In an inactive state, a transcription factor subunit awaits an activation signal from the membrane phosphorylation cascade. Upon phosphorylation on the Ser residues in the transactivation domain, it dimerizes, shuttles into the nucleus, and serves in gene transcription. A missense mutation X in the transactivation domain is a recessive loss-of-function mutation. You observe that a heterozygous mutation Y in the dimerization domain acts as a dominant-negative mutation. Which of the following molecular phenotypes is most likely observed in the presence of mutation Y?",
            "loss of protein dimerization and wild-type phenotype",
            "protein aggregation and loss-of-function phenotype",
            "protein degradation and loss-of-function of the wild-type allele",
            "change of protein conformation and gain-of-function phenotype",
            2
        ],
        "correct_answer": 2,
        "n": "abstracted_workflow_desc_2_157",
        "response": "A dominant-negative mutation in the dimerization domain yields mutant subunits that still dimerize with wild-type monomers, forming inactive complexes. These mixed dimers effectively sequester functional protein into nonfunctional aggregates, abolishing transcriptional activity. Options A, C, and D conflict with this mechanism\u2014A) implies no dimerization, C) requires degradation rather than sequestration, and D) suggests a gain of function\u2014so B) correctly describes protein aggregation and loss-of-function.\n\nAnswer:B)",
        "sub_tasks_text": "Sub-task 1 output: thinking - To answer Sub-task 1, I first recalled each step of activation: in the inactive state the transcription\u2010factor (TF) subunit resides in the cytoplasm awaiting a phosphorylation signal. Upon receiving an upstream membrane\u2010associated kinase cascade, specific serine residues in its transactivation domain become phosphorylated. This post\u2010translational modification alters the conformation of the TF, exposing or stabilizing the dimerization interface. Two phosphorylated monomers then associate via their dimerization domains to form an active homodimer. Dimerization typically unmasks or creates a nuclear localization signal (NLS), allowing the TF complex to be recognized by the nuclear import machinery. The dimer translocates into the nucleus, binds its cognate DNA response elements through its DNA\u2010binding domain, recruits coactivators and RNA polymerase II, and drives transcription of target genes.; answer - Under normal conditions, the transcription\u2010factor subunit is synthesized and remains monomeric in the cytoplasm. A membrane\u2010proximal kinase cascade phosphorylates serine residues in its transactivation domain, inducing a conformational change that allows two phospho\u2010TF monomers to dimerize via their dimerization domains. Dimerization exposes the nuclear localization signal, enabling the complex to enter the nucleus. Once inside, the TF dimer binds specific DNA elements and recruits coactivators and the transcriptional machinery to initiate gene transcription.\n<SEPERATOR>\nSub-task 2 output: thinking - Mutation X lies in the transactivation domain, which harbors the key serine residues phosphorylated to trigger the conformational change needed for dimerization and coactivator recruitment. A missense change here would prevent proper phosphorylation and/or cripple the interface that binds transcriptional coactivators. As a result, even though monomers may still fold and perhaps dimerize by mass action, the phosphorylated form cannot form a transcriptionally competent complex. In homozygotes (recessive), both alleles carry the defective domain, so no functional TF dimer reaches the nucleus or activates target genes. In heterozygotes, the wild-type allele is sufficient to supply normal transactivation function, so the loss is masked.; answer - Mutation X abolishes serine phosphorylation in the transactivation domain, preventing themonos from undergoing the necessary conformational change for dimerization/coactivator binding. Consequently, no functional TF dimer forms to enter the nucleus or drive target gene transcription in homozygotes, while heterozygotes remain phenotypically normal.\n<SEPERATOR>\nSub-task 3 output: thinking - Dominant-negative mutations produce mutant protein subunits that retain the ability to interact (e.g., dimerize) with wild-type subunits but disable the function of the resulting complex. In a transcription factor that must dimerize to become active, a mutant dimerization-domain allele can still bind the wild-type monomer yet block DNA binding, nuclear import, or coactivator recruitment. As a result, even though one allele is normal, the mixed dimers are nonfunctional, suppressing overall TF activity and yielding a phenotype more severe than simple haploinsufficiency.; answer - Dominant-negative mutations in dimerization domains produce mutant subunits that still bind wild-type partners, forming nonfunctional heterodimers. These defective complexes cannot undergo the conformational changes, nuclear translocation, or DNA binding required for transcriptional activation, thereby blocking the activity of the wild-type protein and causing a loss-of-function phenotype despite one normal allele.\n<SEPERATOR>\nSub-task 4 output: thinking - Sub-task 2 showed that mutation X in the transactivation domain blocks phosphorylation and coactivator binding but is recessive because wild-type monomers can still dimerize and function. Sub-task 3 defined a dominant-negative mutation in the dimerization domain as one whose protein product still binds wild-type monomers but cripples the activity of the resulting dimer. In a heterozygote with mutation Y, half the monomers are mutant, and they preferentially form mixed WT\u2013mutant dimers. These heterodimers cannot undergo the conformational change, translocate to the nucleus, or bind DNA/coactivators, effectively sequestering wild-type proteins into inactive complexes. Thus even though one allele is normal, overall transcription factor activity is lost.; answer - The heterozygous dominant\u2010negative mutation Y produces mutant subunits that still dimerize with wild\u2010type monomers but render the dimers nonfunctional, sequestering the normal protein into inactive complexes and causing an overall loss\u2010of\u2010function phenotype.\n<SEPERATOR>\nSub-task 5 output: thinking - A dominant-negative mutation in the dimerization domain yields mutant subunits that still dimerize with wild-type monomers, forming inactive complexes. These mixed dimers effectively sequester functional protein into nonfunctional aggregates, abolishing transcriptional activity. Options A, C, and D conflict with this mechanism\u2014A) implies no dimerization, C) requires degradation rather than sequestration, and D) suggests a gain of function\u2014so B) correctly describes protein aggregation and loss-of-function.; answer - B)"
    }
]